Deep sternal wound infection after cardiac surgery by Hiroshi Kubota et al.
Kubota et al. Journal of Cardiothoracic Surgery 2013, 8:132
http://www.cardiothoracicsurgery.org/content/8/1/132RESEARCH ARTICLE Open AccessDeep sternal wound infection after cardiac surgery
Hiroshi Kubota1*, Hiroaki Miyata2, Noboru Motomura2, Minoru Ono3, Shinichi Takamoto2, Kiyonori Harii4,
Norihiko Oura4, Shinichi Hirabayashi5 and Shunei Kyo3Abstract
Background: Deep sternal wound infection (DSWI) is a serious postoperative complication of cardiac surgery. In
this study we investigated the incidence of DSWI and effect of re-exploration for bleeding on DSWI mortality.
Methods: We reviewed 73,700 cases registered in the Japan Adult Cardiovascular Surgery Database (JACVSD)
during the period from 2004 to 2009 and divided them into five groups: 26,597 of isolated coronary artery bypass
graft (CABG) cases, 23,136 valvular surgery cases, 17,441 thoracic aortic surgery cases, 4,726 valvular surgery plus
CABG cases, and 1,800 thoracic aortic surgery plus CABG cases. We calculated the overall incidence of postoperative
DSWI, incidence of postoperative DSWI according to operative procedure, 30-day mortality and operative mortality
of postoperative DSWI cases according to operative procedure, 30-day mortality and operative mortality of
postoperative DSWI according to whether re-exploration for bleeding, and the intervals between the operation and
deaths according to whether re-exploration for bleeding were investigated. Operative mortality is defined as in-
hospital or 30-day mortality. Risk factors for DSWI were also examined.
Results: The overall incidence of postoperative DSWI was 1.8%. The incidence of postoperative DSWI was 1.8% after
isolated CABG, 1.3% after valve surgery, 2.8% after valve surgery plus CABG, 1.9% after thoracic aortic surgery, and
3.4% after thoracic aortic surgery plus CABG. The 30-day and operative mortality in patients with DSWI was higher
after more complicated operative procedures. The incidence of re-exploration for bleeding in DSWI cases was
11.1%. The overall 30-day/operative mortality after DSWI with re-exploration for bleeding was 23.0%/48.0%, and it
was significantly higher than in the absence of re-exploration for bleeding (8.1%/22.0%). The difference between
the intervals between the operation and death according to whether re-exploration for bleeding had been
performed was not significant. Age and cardiogenic shock were significant risk factors related to re-exploration for
bleeding, and diabetes control was a significant risk factor related to DSWI for all surgical groups. Previous CABG
was a significant risk factor related to both re-exploration for bleeding and DSWI for all surgical groups.
Conclusions: The incidence of DSWI after cardiac surgery according to the data entered in the JACVSD registry
during the period from 2004 to 2009 was 1.8%, and more complicated procedures were followed by higher
incidence and mortality. When re-exploration for bleeding was performed, mortality was significantly higher than
when it was not performed. Prevention of DSWI and establishment of an effective appropriate treatment for DSWI
may improve the outcome of cardiac surgery.
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Infection of the sternotomy wound is a serious complica-
tion of open heart surgery. It is a potentially devastating
and occasionally fatal complication.
The aim of this study was to determine the overall
incidence of DSWI after cardiac surgery, the incidence
of DSWI according to each operative procedure, the
overall 30-day mortality and operative mortality in
patients with DSWI, the 30-day mortality and operative
mortality in patients with DSWI according to operative
procedure, the effect of re-exploration surgery due to
postoperative bleeding on DSWI mortality, and risk fac-
tors related to re-exploration for bleeding and DSWI in
a series of cases recorded in JACVSD.
Methods
Because this study involved human subjects, approval
was sought and obtained from the Institutional Review
Board of each participating hospital. Informed consent
had been obtained from each patient to allow his or her
data to be entered into the JACVSD.
The JACVSD was inaugurated in 2000 to make it possible
to assess outcomes after cardiovascular surgical procedures
on a multicenter basis. As of 2012, it captures clinical
information from 485 hospitals 2012 (82% of all units
performing cardiac surgery in 2012), and we included data
from the 178 hospitals that had enrolled by December 2009
in this study. The usage of database for this study was ap-
proved by the Data Utilization Committee in the JACVSD.
Of the 81,796 adult cases recorded in the JACVSD during
the period from 2004 to 2009, we reviewed the 73,700 cases
that did not involve miscellaneous cardiac procedures
(8,096 cases) and divided them into five groups: 26,597
isolated coronary artery bypass graft (CABG) cases, 23,136
valvular surgery cases, 17,441 thoracic aortic surgery
cases, 4,726 valvular surgery plus CABG cases, and
1,800 thoracic aortic surgery plus CABG cases. We
investigated the following in regard to these 26,597 cases:
1. Overall incidence of postoperative DSWI
2. Incidence of postoperative DSWI according to
operative procedure.
3. Overall incidence of re-exploration for bleeding in
patients without/with postoperative DSWI.
4. Incidence of re-exploration for bleeding in
patients without/with postoperative DSWI
according to operative procedure.
5. Overall 30-day mortality and operative mortality in
patients with postoperative DSWI.
6. The 30-day mortality and operative mortality of
DSWI cases for each operative procedure.
7. Overall 30-day mortality and operative mortality
in patients with DSWI according to whether
re-exploration for postoperative bleeding.8. The 30-day mortality and operative mortality in
patients with DSWI after each operative procedure
according to whether re-exploration for
postoperative bleeding.
9. The intervals between the operation and death and
effect of re-exploration for bleeding on mortality.
Risk models of re-exploration for bleeding and DSWI
for each procedure were referred in the (Appendix).
Statistical analysis
Operative mortality is defined as in-hospital or 30-day
mortality (whichever longer), which is equivalent to “the
30-day operative mortality” as defined in the STS National
Adult Cardiac Surgery Database.
Also definition of DSWI in JACVSD were “indicate
whether the patient, within 30 postoperatively, had a
deep sternal infection involving muscle, bone, and/or
mediastinum requiring operative intervention, and have
any of the following conditions: 1. Wound opened with
excision of tissue (I&D) or re-exploration of mediastinum.
2. Positive culture. 3. Treatment with antibiotics.”
Results
1. Overall incidence of postoperative DSWI was 1.8%.
2. The incidence of postoperative DSWI was 1.8% in
isolated CABG group, 1.3% in valvular surgery, 2.8%
in valvular surgery concomitant with CABG, 1.9% in
thoracic aortic surgery, 3.4% in thoracic aortic
surgery concomitant with CABG.
3. Overall incidence of re-exploration for bleeding in
patients without/with postoperative DSWI was 3.6/
11.1%* (*: p < 0.05).
4. The incidence of re-exploration for bleeding
without/with DSWI according to operative
procedure was 1.8%/6.9%* in isolated CABG group,
3.8/11.8%* in valvular surgery, 4.9/6.1% (n.s.) in
valvular surgery concomitant with CABG, 5.4/15.9%
* in thoracic aortic surgery, 9.1/25.8%* in thoracic
aortic surgery concomitant with CABG.
5. Overall 30-day mortality and operative mortality in
patients with DSWI was 9.7% and 25.8% respectively.
6. The 30-day mortality in patients and operative
mortality with DSWIwere 5.2% and 19.0% in isolated
CABG, 10.5% and 23.0% in valvular surgery, 10.0%
and 22.3% in valvular surgery concomitant with
CABG, 14.1% and 34.9% in thoracic aortic surgery,
17.7% and 50.0% in thoracic aortic surgery
concomitant with CABG respectively.
7. Overall 30-day mortality and operative mortality in
patients with DSWI with re-exploration for bleeding
was 23.0% and 48.0% respectively. It was
significantly higher than 30-day mortality in patients
Table 2 Incidence of re-exploration for bleeding in
patients with postoperative DSWI
CABG Valve Valve +
CABG
TA TA + CABG
Overall incidence of
re-exploration for bleeding
1.8 3.8 4.9 5.4 9.1
3.6 (%)
Incidence of re-exploration
for bleeding in DSWI cases
6.9 11.8 6.1 15.9 25.8
11.1 (%)
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bleeding (8.1% and 22.0%, p < 0.05).
8. The 30-day mortality and operative mortality in
patients with DSWI of each operative procedure
without/with re-exploration due to postoperative
bleeding was 4.3/18.2%* and 17.5/39.4%* in isolated
CABG, 8.8/22.9%* and 20.7/40.0%* in valvular
surgery, 10.7/0% (n.s.) and 22.1/25.0% (n.s.) in
valvular surgery concomitant with CABG, 11.6/
26.9%* and 30.5/57.7%* in thoracic aortic surgery,
13.0/31.3%* and 43,5/68.8% (n.s.) in thoracic aortic
surgery concomitant with CABG respectively.
9. In dead cases, duration from the operation to
death without/with re-exploration for bleeding
was 78.1/68.2 days. According to procedurs,
93.4/63.1 days (n.s.) in isolated CABG, 55.5/62.2 days
(n.s.) in valvular surgery, 62.4/41.5 days (n.s.)
in valvular surgery concomitant with CABG,
77.5/67.2 days (n.s.) in thoracic aortic surgery
group, 95.7/90.0 days (n.s.) in thoracic aortic
surgery concomitant with CABG (n.s.), (Table 1.
Result 3 and 4 were separately shown in Table 2).
Discussion
According to the literature, the incidence of DSWI after
cardiac surgery has been variously reported as between 0.8
and 5.0% [1-7]. This postoperative complication is a serious
one, being responsible for a mortality rate varies between
19% and 29% in different series of adult cardiac surgical
patients [1-7]. Based on JACVSD registered data from
2004 to 2009, the overall incidence of DSWI after cardiac
surgery was 1.8%, as for each operative procedure, the inci-
dence of postoperative DSWI was 1.8% in isolated CABG
group, 1.3% in valve group, 2.8% in valve with CABG
group, 1.9% in thoracic aorta group and 3.4% in thoracic
aorta with CABG group. When operative procedure
concomitant with CABG was done, the incidence of post-














Duration until death Re-exploration for bleeding
- 78.1
+ 68.2
DSWI; deep sternal wound infection, CABG; coronary artery bypass graft, TA; thoracicisolated original valve and thoracic aortic procedure.
Internal thoracic artery use, prolonged operative time
and longer cardiopulmonary bypass time are possible
mechanisms to explain these increased rates of DSWI.
Postoperative DSWI patients showed very high
30-day/operative mortality. Overall, it was 9.7/25.8% and
as for each procedure, thoracic aortic surgery concomitant
with CABG showed the highest mortality, aortic related
surgery and valve related surgery followed, coronary bypass
surgery showed the lowest. These results represent that
additionally to the above described well-known risk factors
to augment the risk of DSWI after cardiac surgery, deep
hypothermia and usage of synthetic graft may worsen the
result of DSWI related to aortic surgery.
These results show that prevention of postoperative
DSWI and establishment of the appropriate treatment
for postoperative DSWI are the important factors to
reduce the mortality after cardiac surgery.
Large retrospective and prospective outcome studies
have identified epidemiologic factors associated with
DSWI. A partial list of commonly cited risks includes
advanced age, obesity, diabetes, smoking, prolonged
operative time, use of internal thoracic artery conduits,
hemodyalisis, reoperative surgery and prolonged cardio-
pulmonary bypass time [3,7,8]. In our study, previous
CABG history was the most significant risk factor relatedCABG Valve Valve + CABG TA TA + CABG
ases) 26,597 23,136 4,726 17,441 1,800
) 1.8 1.3 2.8 1.9 3.4
) 5.2 10.5 10.0 14.1 17.7
(%) 4.3 8.8 10.7 11.6 13.0
0 (%) 18.2 22.9 0 26.9 31.3
) 19.0 23.0 22.3 34.9 50.0
0 (%) 17.5 20.7 22.1 30.5 43.5
0 (%) 39.4 40.0 25.0 57.7 68.8
(days) 93.4 55.5 62.4 77.5 95.7
(days) 62.1 62.2 41.5 67.2 90.0
aortic surgery.
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gical groups. Age and cardiogenic shock were
significant risk factors related to re-exploration for
bleeding for all surgical groups, male gender, emergent or
salvage operation, and operation combined with CABG
were significant risk factors related to re-exploration for
bleeding in two of three surgical groups. Diabetes control
was a significant risk factor related to DSWI for all surgical
groups. BMI, renal failure, COPD, cardiogenic shock,
administration of inotropic agents, and triple vessel disease
were significant risk factors related to DSWI in two of three
groups. Aortic rupture and aortic arch operation were
significant risk factors related to both re-exploration for
bleeding and DSWI in thoracic aortic surgery group.
Thirty-day/operative mortality in patients with DSWI
with re-exploration for bleeding was significantly higher
than DSWI without re-exploration in all operative proced-
ure except two. Although there was no thirty-day mortality
in valvular surgery concomitant with CABG group with
re-exploration for bleeding, there was no significant
between without re-exploration group.
It is known that patients who need re-exploration for
bleeding after cardiac surgery are at higher risk of compli-
cations, morbidity and mortality. In our study, the inci-
dence of re-exploration for bleeding in DSWI cases was
11.1% and it was threefold as many as overall incidence of
re-exploration for bleeding. Patients requiring resternotomy
are at greater risk from the hazards of transfusion reactions,
viral infections, suppression of the immune system [9,10].
Canadyova et al. described that risk factors associated
with higher in-hospital mortality after re-exploration for
bleeding and tamponade include delayed resternotomy,
higher levels of lactate, lower levels of hematoclit before
revision, older age, more complex cardiac procedures, redo
operations, longer cardiopulmonary bypass, renal failure
and diabetes mellitus. If the time until re-exploration is
prolonged, risk of complications, morbidity and mortality
will elevate [11]. Kristensen et al. reported a case-note
review on propensity-matched patients to assess the
outcome of reoperation for bleeding regarding morbidity
and mortality. In total, 101 cases (7.0%) among 1452
consecutive patients undergoing cardiac surgery using
cardiopulmonary bypass underwent surgical re-exploration
due to excessive postoperative bleeding [12]. Significant risk
factors for reoperation for bleeding after cardiac
surgery was low ejection fraction, high EuroSCORE,
procedures other than isolated CABG, elongated time
on cardiopulmonary bypass, low body mass index,
diabetes mellitus and preoperatively elevated s-creatinine.
Reoperated patients significantly had a greater increase in
postoperative s-creatinine and higher mortality. Surviving
reoperated patients significantly had a lower EuroSCORE
and a shorter time on cardiopulmonary bypass compared
with non-survivors. The average time to re-operation was155 min longer for non-survivors when compared with
survivors. Considering these results, first of all, to
secure hemostasis to prevent re-exploration for
bleeding is important to prevent DSWI, and when
re-exprolation for bleeding is required, prevention
and earlier decision should be made to decrease DSWI
after cardiac surgery.
Deniz et al. studied the effectiveness of negative pressure
wound therapy compared with conventional treatment
outcomes at postoperative mediastinitis after cardiac
surgery in 90 patients. Because the 90-days mortality was
found significantly lower (8.5% vs. 23.2%) and overall
survival at 1 year was significantly better (91.5% vs.
76.7%) in the negative pressure wound group than in
the conventionally treated group, they concluded that
negative pressure wound therapy was safe and reliable
option in mediastinitis after cardiac surgery, with
excellent survival and low failure rate when compared
with conventional treatments [13].
Sachithanadan et al. assessed the impact of DSWI on
in-hospital mortality and mid-term survival following
cardiac surgery in 4586 consecutive adult patients who
underwent cardiac surgery via a median sternotomy. DSWI
requiring revision surgery developed in 1.65% patients.
Age, diabetes, a smoking history and ventilation time
were identified as independent predictors of a DSWI.
DSWI patients were more likely to develop renal
failure, require reventilation and a tracheostomy postoper-
atively. However, they detected that DSWI is not an
independent predictor of higher in-hospital mortality
or reduced mid-term survival compared with the
patients without DSWI following cardiac surgery.
They treated using vacuum assisted closure therapy in
81.5% patients [14].
Because VAC system was approved to commercial use
in 2010 in Japan and presented data was pre-approval
VAC system era, their results suggest that development of
the appropriate treatment surely contribute to improve
the prognosis of DWSI after cardiac surgery.
Conclusion
The incidence of deep sternal wound infection after
open heart surgery was 1.8% in JACVSD registry from
2004 to 2009. Once, deep sternum infection occurs, it
showed high mortality. Especially, more invasive procedure
showed higher mortality. When re-exploration due to
bleeding was required, the mortality elevated extremely
high. DSWI is severe complication after open heart surgery.
Prevention of DSWI, avoiding to re-exploration for
bleeding, earlier decision for re-exploration for bleeding,
contrivance of appropriate means of wound closure,
and development of the appropriate treatment for
DSWI are important to improve the prognosis of
cardiac surgery.
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In addition to this analysis we also refer risk model of
DSWI and re-exploration for bleeding for each proce-
dures (Details of model development and evaluation
were mentioned at http://www.jacvsd.umin.jp). Previous
CABG history was a significant risk factor related to
both re-exploration for bleeding and DSWI for all
surgical groups. Age and cardiogenic shock were
significant risk factors related to re-exploration for
bleeding, and diabetes control was a significant risk













COPD (Mild, Moderate, Severe)
Carotid artery lesion (Yes(unilateral, bilateral))
Extracardiac arteriopathy (Yes(Thoracic aorta, Peripheral artery including abdo
Extracardiac arteriopathy (Peripheral artery including abdominal aorta)
Consciousness Disorder within 24 hours (Yes)
Previous surgery (CABG)(Yes)











Mitral Insufficiency (IIand over)
Tricuspid Insufficiency (IIand over)
Operation status (Emergent, Salvage)gender, emergent or salvage operation, and operation
combined with CABG were significant risk factors related
to re-exploration for bleeding in two of three surgical
groups. Body mass index (BMI), renal failure, chronic
obstructive pulmonary disease (COPD), cardiogenic
shock, administration of inotropic agents, and triple vessel
disease were significant risk factors related to DSWI in
two of three groups. Aortic rupture and aortic arch
operation were significant risk factors related to both
re-exploration for bleeding and DSWI in thoracic aortic
surgery group (Table 3).sternum wound infection
Re-exploration for bleeding Deep sternum wound
infection
IsolatedCABG Valve Aorta Isolated
CABG
Valve Aorta
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Table 3 Risk model for re-exploration for bleeding and deep sternum wound infection (Continued)
Operation status (Urgent, Emergent, Salvage) ━ ━ 1.78
CABG (Yes) ━ 1.24 1.81 ━ 1.59
Unplanned CABG(Yes)
Aortic valve surgery (Yes) 1.32 1.39
Aortic valve surgery (Replacement) ━ 1.59 ━
Combined valve surgery ━ 1.21 ━ ━ ━
Aortic Aneurysm Type(Dissection) ━ ━ 1.38 ━ ━
Aortic Aneurysm Type(Pseudoaneurysm) ━ ━ ━ ━ 2.09
Cause of operation(Rupture) ━ ━ 1.62 ━ ━ 1.40
Operation site (Arch) ━ ━ 1.4 ━ ━ 2.12
Operation site (Root) ━ ━ ━ ━ 1.45
Operation site (Ascending) ━ ━ ━ ━ 1.47
Operation site (Thoracoabdominal) ━ ━ 1.65 ━ ━
Maze operation (Yes) ━ ━ 1.88 ━ ━
━; not included in questionnaire, BSA; body surface area, BMI; body mass index, COPD; chronic obstructive pulmonary disease, CVA; cerebrovascular accident, TIA;
transient ischemic attack, RIND; reversible ischemic neurological deficit, CCS; Canadian cardiovascular society classification, NYHA; New York heart association, LV;
left ventricle.
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